ALL ALS: Establishing a National Research Consortium to Accelerate ALS Drug Discovery and Harmonize Global Data
Time: 5:00 pm
day: Conference Day One PM
Details:
- ALL ALS is an NIH-funded initiative to enroll nearly all ALS patients in the U.S., collecting clinical data, biosamples, and digital health measures through site-based and remote methods
- Integrating datasets from Target ALS, Answer ALS, and AMP-ALS into a public portal to accelerate research and therapeutic development
- Harmonizing ALS research data with other neurological diseases, such as Parkinson’s and FTD, to explore shared mechanisms and disease progression
- Partnering with international groups, ALL ALS aims to expand its reach, unify global research efforts, and drive biomarker discovery
